Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 42 (3) , 238-244
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Myeloproliferative NeoplasmsNew England Journal of Medicine, 2017
- Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasmsBlood, 2017
- Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasmsLeukemia, 2015
- SomaticCALRMutations in Myeloproliferative Neoplasms with NonmutatedJAK2New England Journal of Medicine, 2013
- Somatic Mutations of Calreticulin in Myeloproliferative NeoplasmsNew England Journal of Medicine, 2013
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohortBlood, 2008
- Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disordersBlood, 2008
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005